Article
[Studies of gene therapy for Parkinson's disease].
Rinsho shinkeigaku = Clinical neurology - 1 Nov 2009
Mochizuki Hideki
Abstract excerpt
Currently, four Phase I clinical trials are underway utilizing recombinant adeno-associated viral (rAAV) vectors for the treatment of Parkinson's disease. The vehicle used mainly for gene delivery to the human brain is rAAV vector, which is non-pathogenic and non-self-amplifying. At present, the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
